+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Short article: Small intestinal mucosal injury in patients taking chemotherapeutic agents for solid cancers

Short article: Small intestinal mucosal injury in patients taking chemotherapeutic agents for solid cancers

European Journal of Gastroenterology and Hepatology 29(5): 568-571

Chemotherapy for cancer is a systemic treatment often associated with side effects than can be debilitating and, in some cases, life-threatening. Few data are available on intestinal enterotoxicity. Wireless video capsule endoscopy (VCE) is a noninvasive method of imaging the small intestine. This study presents the results of VCE in patients with solid tumors undergoing antineoplastic regimens with agents, notably for toxicity for the gastrointestinal mucosa (i.e. carboplatin, cyclophosphamide, 5-fluorouracil, methotrexate, and cisplatin). The capsule endoscopy procedure was performed 4-13 days after the end of the antineoplastic course. Each patient received a polyethylene-glycol solution (1000 mg×2 in 2 l of water) for bowel preparation and fasted for 10 h before ingestion of the capsule. Videos were evaluated by one operator, supervised by a second operator, and conclusions were drawn by an expert reader. Twenty (age range: 38-77 years) patients were evaluated. The cecum was reached in 70% before exhaustion of the battery. The video capsule showed small widespread intestinal ulcerations in 25% and erosions in only one patient. The villus architecture appeared normal in all. VCE detected metastases in one patient with a melanoma. Few patients had more than one lesion. All capsules were passed in the stool. Our results suggest that chemotherapy in patients with solid cancers is associated with minimal visual small bowel injury. Factors other than damage of the intestinal mucosa causing loss of epithelium are likely involved in gastrointestinal toxicity and related symptoms.

(PDF emailed within 0-6 h: $19.90)

Accession: 060245932

Download citation: RISBibTeXText

PMID: 28350747

DOI: 10.1097/MEG.0000000000000828

Related references

Prevalence of gastroduodenal mucosal injury in asymptomatic patients taking antiplatelet agents in Japan. International Journal of Clinical Pharmacology and Therapeutics 47(12): 722-725, 2010

Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal antiinflammatory drugs and controls. Journal of Clinical Gastroenterology 34(5): 529-532, 2002

Gastroduodenal mucosal injury during hepatic arterial infusion of chemotherapeutic agents. Lack of cytoprotection by prostaglandin E1 analogue. Gastroenterology 92(3): 566-569, 1987

Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancer. Clinical Lung Cancer 2 Suppl 1: S23-S28, 2004

Short-chain fatty acid induces intestinal mucosal injury in newborn rats and down-regulates intestinal trefoil factor gene expression in vivo and in vitro. Journal of Pediatric Gastroenterology and Nutrition 41(5): 607-611, 2005

Gastric emptying and small intestinal mucosal injury in rats. Gastroenterology 69(6): 1246-1253, 1975

Short article: Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children. European Journal of Gastroenterology and Hepatology 29(4): 396-399, 2016

16,16-Dimethyl prostaglandin E2 reduced chenodeoxycholate-induced small intestinal mucosal injury in the rat. Journal of Laboratory & Clinical Medicine 110(4): 387-395, 1987

Visible small-intestinal mucosal injury in chronic NSAID users. Clinical Gastroenterology and Hepatology 3(1): 55-59, 2005

Adaptive cytoprotection against ethanol-induced small intestinal mucosal injury. Canadian Journal Of Physiology & Pharmacology. 74(5): 598-602, 1996

Histidine decarboxylase is identified as a potential biomarker of intestinal mucosal injury in patients with acute intestinal obstruction. Molecular Medicine 17(11-12): 1323-1337, 2012

Prevention and treatment of gastric mucosal injury in patients taking low-dose aspirin. Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl 7: 450-454, 2012

Does rebamipide prevent gastric mucosal injury in patients taking aspirin and clopidogrel?. Digestive Diseases and Sciences 59(8): 1671-1673, 2014

Prolonged small intestinal mucosal injury as a primary cause of intractable diarrhea of infancy. Lebenthal, E (Ed ) Nestle Nutrition Workshop Series, Vol 6 Chronic Diarrhea in Children; Workshop, Caracas, Venezuela, Jan 31-Feb 4, 1983 Xix+568p Raven Press: New York, N Y , Usa Illus P5-30, 1984

Extent and duration of small intestinal mucosal injury in intractable diarrhea of infancy. Pediatrics 66(5): 730-735, 1980